NICVDImagingFellowship (@nicvdimaging) 's Twitter Profile
NICVDImagingFellowship

@nicvdimaging

NICVD, The leading cardiac care hospital.
#WhyCMR
#echofirst
#yesCCT

ID: 1653762673643859971

calendar_today03-05-2023 14:05:44

266 Tweet

153 Takipçi

49 Takip Edilen

Sabha Bhatti MD (@sabhabhatti) 's Twitter Profile Photo

We are thrilled to announce that the Past president of ASNC Society Mouaz Al-Mallah, M.D MSc will be presenting the role of #nuclearcardiology in Valvular ❤️ disease @ #3rdPHVCIS2025 🇵🇰 Don’t miss ! Registration Deadline today #CVNuc NICVDImagingFellowship NICVD Akshay Khandelwal MD MBA

We are thrilled to announce that the Past president of  <a href="/MyASNC/">ASNC Society</a> <a href="/almallahmo/">Mouaz Al-Mallah, M.D MSc</a> will be presenting the role of #nuclearcardiology in Valvular ❤️ disease @ #3rdPHVCIS2025 🇵🇰
Don’t miss ! Registration Deadline today #CVNuc 
<a href="/NicvdImaging/">NICVDImagingFellowship</a> 
<a href="/nicvd_karachi/">NICVD</a> 
<a href="/KhandelwalMD/">Akshay Khandelwal MD MBA</a>
Sabha Bhatti MD (@sabhabhatti) 's Twitter Profile Photo

📣📣 #3rdPHVCIS2025 🇵🇰 🫀 Registration closes in few hours. We have had an excellent response as usual and will not be able to take walk ins without prior registration! NICVDImagingFellowship We also have a surprise at the end of the conference (not listed on agenda) 👇Final agenda👇

📣📣
#3rdPHVCIS2025 🇵🇰 🫀
Registration closes in few hours. We have had an excellent response as usual and will not be able to take walk ins without prior registration! <a href="/NicvdImaging/">NICVDImagingFellowship</a> 
We also have a surprise at the end of the conference (not listed on agenda)

👇Final agenda👇
NICVD (@nicvd_karachi) 's Twitter Profile Photo

NICVD hosted the 3rd Annual Pakistan Heart Valve & Cardiac Imaging Summit 2025 at PC Hotel Karachi, uniting experts to share advances in cardiac imaging and valve care. View more pictures here🔗 bit.ly/3Sb7sZJ #NICVD #CardiacSummit2025 #InnovationInCardiology

NICVD hosted the 3rd Annual Pakistan Heart Valve &amp; Cardiac Imaging Summit 2025 at PC Hotel Karachi, uniting experts to share advances in cardiac imaging and valve care.
View more pictures here🔗 bit.ly/3Sb7sZJ
#NICVD #CardiacSummit2025 #InnovationInCardiology
NICVD (@nicvd_karachi) 's Twitter Profile Photo

The 3rd Annual Cardiac Imaging Summit 2025 at NICVD showcased Pakistan’s strides in cardiac imaging and NICVD’s key role in training future cardiologists. #CardiacSummit2025 #NICVD #FutureOfCardiology

NICVD (@nicvd_karachi) 's Twitter Profile Photo

The 3rd Heart Valve & Cardiac Imaging Summit 2025 saw 600+ participants and 20 expert talks, highlighting advances in imaging and heart valve care. #CardiacSummit2025 #NICVD #FutureOfCardiology

NICVD (@nicvd_karachi) 's Twitter Profile Photo

At the 3rd Summit 2025, experts stressed teamwork and precise imaging for structural heart disease, showing NICVD’s role in advancing cardiac care. #CardiacSummit2025 #NICVD #AdvancedCardiology

NICVD (@nicvd_karachi) 's Twitter Profile Photo

The 3rd Cardiac Summit 2025 blended imaging and valve disease in one impactful event, showcasing NICVD’s drive for progress in heart care. #NICVD #CardiacSummit2025 #HeartValve #MedicalAdvocacy

NICVD (@nicvd_karachi) 's Twitter Profile Photo

The 3rd Heart Valve & Imaging Summit 2025 united top experts to share insights and boost collaboration, advancing valve care and outcomes across Pakistan. #CardiacSummit2025 #NICVD #CardiologyAdvancement

NICVD (@nicvd_karachi) 's Twitter Profile Photo

Dr. Shazia Mohsin (SIUT) praised the 2025 Summit for its innovation, strong content, and NICVD’s role in advancing tech and expertise through world-class conferences. #CardiacSummit2025 #NICVD

NICVD (@nicvd_karachi) 's Twitter Profile Photo

At the 2025 Summit, experts urged adopting modern, non-surgical heart treatments. NICVD’s advanced tech is improving outcomes and offering safer options. #CardiacSummit2025 #NICVD #HeartCareInnovation

NICVD (@nicvd_karachi) 's Twitter Profile Photo

At the 2025 Summit, experts stressed imaging's role in early valve disease detection—key for tackling conditions like rheumatic heart disease. #CardiacSummit2025 #NICVD #EarlyDiagnosis #HeartCare

NICVD (@nicvd_karachi) 's Twitter Profile Photo

The 3rd Summit 2025 featured global voices debating overlooked imaging issues, boosting knowledge and advancing cardiology. #NICVD #CardiacSummit2025 #HeartValveSummit #CardiologyAdvancement

NICVD (@nicvd_karachi) 's Twitter Profile Photo

At the 2025 Summit, expert talks and lively debates made it a top learning event for cardiologists. Hybrid format enabled broad access. Congrats to Prof. Saba Bhatti & NICVD! #NICVD #MedicalEducation

NICVD (@nicvd_karachi) 's Twitter Profile Photo

Experts at the 3rd Summit emphasized the urgent need to fight rheumatic heart disease and advance valvular care through education and teamwork. #CardiacSummit2025 #RheumaticHeartDisease #NICVD

Dr Muhammad Zeb (@zebcardio) 's Twitter Profile Photo

Is PMBC expected to replace MVR in most of the cases of rheumatic mitral stenosis irrespective of wilkin's scores with good expertise in PMBC in the current Era ? NICVDImagingFellowship Sabha Bhatti MD

Is PMBC expected to replace MVR in most of the cases of rheumatic mitral stenosis irrespective of wilkin's scores with good expertise in PMBC in the current Era ?
<a href="/NicvdImaging/">NICVDImagingFellowship</a> 
<a href="/SabhaBhatti/">Sabha Bhatti MD</a>
Sabha Bhatti MD (@sabhabhatti) 's Twitter Profile Photo

I would like to thank everyone who attended the meeting this past Saturday. Many months of planning went into and it was visible. It was the best attended summit to date with the best agenda we've ever had. See you next year! IA

João Cavalcante (@joaolcavalcante) 's Twitter Profile Photo

Treat the valve AND the myocardium when facing severe AS+amyloidosis. Both AVR and tafamidis independently ↓ mortality Dual therapy=best outcomes w/ similar survival to lone AS+AVR. Dual pathology is common (~13%) warranting RCT. tinyurl.com/2zmpht8x Bravo Thomas Treibel! 👏🏻

Treat the valve AND the myocardium when facing severe AS+amyloidosis. Both AVR and tafamidis independently ↓ mortality
Dual therapy=best outcomes w/ similar survival to lone AS+AVR. Dual pathology is common (~13%) warranting RCT. tinyurl.com/2zmpht8x Bravo <a href="/ThomasTreibel/">Thomas Treibel</a>! 👏🏻